Contamination of salvaged maternal blood by amniotic fluid and fetal red cells during elective Caesarean section

I Sullivan, J Faulds, C Ralph, I Sullivan, J Faulds, C Ralph

Abstract

Background: Cell salvage in obstetrics is still a controversial subject and has yet to be fully embraced. The aim of this exploratory study was to measure amniotic fluid (AF), heparin, and fetal red cell contamination of washed filtered salvaged maternal blood and to investigate differences based on the number of suction devices used.

Methods: Patients undergoing elective Caesarean section were assigned alternately to one of two groups. In Group 1, all blood and AF was collected with one suction. In Group 2, AF was aspirated to waste with a second separate suction device before collection of any blood.

Results: In both groups, alpha-fetoprotein (AFP), squames cells, and heparin were significantly reduced (P<0.001) by the washing and filtering process. Mean AFP levels post-filtration were 2.58 IU ml(-1) in Group 1 and 3.53 IU ml(-1) in Group 2. Squames cells were completely removed in all but two cases. Fetal red blood cells were still present in the final product, range 0.13-4.35%. In Group 1, haemoglobin and haematocrit were higher than in Group 2, with lower white blood cell, AFP, and fetal red cell counts.

Conclusions: This study adds to the growing body of evidence that there is little or no possibility for AF contamination to enter the re-infusion system when used in conjunction with a leucodepletion filter.

References

    1. Catling SJ, Williams S, Fielding A. Cell salvage in obstetrics: an evaluation of the ability of cell salvage combined with leucocyte depletion filtration to remove amniotic fluid from operative blood loss at caesarean section. Int J Obstet Anesth. 1999;8:79–84.
    1. Waters JH, Biscotti C, Potter PS, Phillipson E. Amniotic fluid removal during cell salvage in the cesarean section patient. Anesthesiology. 2000;92:1531–6.
    1. UK National Institute for Health and Clinical Excellence. Intraoperative Blood Cell Salvage in Obstetrics.
    1. Allam J, Cox M, Yentis SM. Cell salvage in obstetrics. Int J Obstet Anesth. 2008;17:37–45.
    1. Thornhill ML, O’Leary AJ, Lussos SA, Rutherford C, Johnson MD. An in-vitro assessment of amniotic fluid removal from human blood through cell saver processing. Anesthesiology. 1991;75:A830.
    1. Fong J, Gurewitsch ED, Kump L, Klein R. Clearance of fetal products and subsequent immunoreactivity of blood salvaged at cesarean delivery. Obstet Gynecol. 1999;93:968–72.
    1. Davies S. What ‘do’ we know about AFE? Int J Obstet Anesth. 2000;9:142.
    1. Murphy M, Pamphilon D, Weatherall D. Prenatal and childhood transfusions. In: Murph M, Pamphilon D, editors. Practical Transfusion Medicine. 2nd Edn. Oxford: Blackwell Publishing; 2005. pp. 97–118.
    1. Health Protection Agency Press Statement. 4th Case of Variant CJD Infection Associated with Blood Transfusion.
    1. Catling S, Joels L. Cell salvage in obstetrics: the time has come. Int J Obstet Gynaecol. 2005;112:131–2.
    1. Water JH. Indications and contraindications of cell salvage. Transfusion. 2004;44:40S–4S.
    1. Catling SJ, Freites O, Krishnan S, Gibbs R. Clinical experience with cell salvage in obstetrics: 4 cases from one UK centre. Int J Obstet Anesth. 2002;11:128–34.
    1. Rebarber A, Lonser R, Jackson S, Copel JA, Sipes S. The safety of intraoperative autologous blood collection and autotransfusion during cesarean section. Am J Obstet Gynecol. 1998;179:715–20.
    1. Potter PS, Waters JH, Burger GA, Mraovic B. Application of cell-salvage during cesarean section. Anesthesiology. 1999;90:619–21.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir